ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 833 • 2013 ACR/ARHP Annual Meeting

    Cardiovascular Diseases In Rheumatoid Arthritis: Can Early Treatment With Disease-Modifying Antirheumatic Drugs Alter The Risk?

    Rishi Desai1, Jaya Rao2, Richard Hansen3, Gang Fang4, Matthew Maciejewski5 and Joel Farley4, 1Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, 2Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, 3Harrison School of Pharmacy, Auburn University, Auburn, AL, 4University of North Carolina, Chapel Hill, NC, 5Duke University, Durham, NC

    Background/Purpose: Atherosclerosis is known to be accelerated in rheumatoid arthritis (RA) patients resulting in an increased cardiovascular (CV) risk. Structural damage to joints occurs aggressively…
  • Abstract Number: 835 • 2013 ACR/ARHP Annual Meeting

    The Association Of Worsening Structural Disease With Trajectories Of Decline In Physical Function In Knee Osteoarthritis:  Results From Two Cohort Studies

    Daniel K. White1, Tuhina Neogi2, Jingbo Niu2, Uyen Sa D.T. Nguyen3, David T. Felson4, Barton L. Wise5, C.E. Lewis6, Michael C. Nevitt7, James Torner8 and Yuqing Zhang4, 1Boston University School of Medicine, Boston, MA, 2Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 3Orthopedics and Physical Rehabilitation, University of Massachusetts Medical School, Worcester, MA, 4Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 5Internal Medicine, Center for Musculoskeletal Health, UC Davis School of Medicine, Sacramento, CA, 6University of Alabama, Birmingham City, Brimingham, AL, 7Epidemiology & Biostatistics, UCSF (University of California, San Francisco), San Francisco, CA, 8Epidemiology, University of Iowa, Iowa City, Iowa City, IA

    Background/Purpose: Knee osteoarthritis (OA) is the most common cause of functional limitation in older adults.  It is not known, however, what proportion progress to a…
  • Abstract Number: 836 • 2013 ACR/ARHP Annual Meeting

    Comprehensive Behavioral Intervention Compared To Standard Of Care Exercise Program After Total Knee Arthroplasty: A Pilot Randomized Trial

    Sara R. Piva1, Maria Beatriz Catelani1 and Gustavo J. Almeida2, 1Physical Therapy, University of Pittsburgh, Pittsburgh, PA, 2Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Although the overall outcome of total knee arthroplasty (TKA) is favorable, surgery alone fails to resolve many of the substantial functional limitations and physical…
  • Abstract Number: 837 • 2013 ACR/ARHP Annual Meeting

    The Validity Of The Satisfaction With Appearance Scale and The Brief Satisfaction With Appearance Scale For Patients With Limited and Diffuse Systemic Sclerosis

    Rina M. Sobel-Fox1, Sarah D. Mills2, Shadi Gholizadeh1, Erin L. Merz2, Philip J. Clements3, Suzanne Kafaja4, Vanessa L. Malcarne2,5, Dinesh Khanna6 and Daniel Furst4, 1Psychology, SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, 2SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, 3University of California, Los Angeles, Department of Medicine, Los Angeles, CA, 4David Geffen School of Medicine, UCLA, Los Angeles, CA, 5San Diego State University, San Diego, CA, 6Division of Rheumatology, University of Michigan Medical School, Ann Arbor, MI

    Background/Purpose: The Satisfaction with Appearance Scale (SWAP) was originally developed to evaluate body image dissatisfaction (BID) among burn victims, and was later adapted for use…
  • Abstract Number: 838 • 2013 ACR/ARHP Annual Meeting

    Recommendations for the Classification and Diagnosis of Fibromyalgia Syndrome Provided By Independently Developed Evidence-Based Interdisciplinary Guidelines Spanning Three Continents

    Mary-Ann Fitzcharles1, Yoram Shir2, Jacob N. Ablin3, Dan Buskila4, Howard Amital5, Peter Henningsen6 and Winfried Häuser7, 1Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 2Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 3Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 4Ben-Gurion University, Beer-Sheva, Israel, 5Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Tel-hashomer, Israel, 6Department Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany, 7Klinikum Saarbrücken, Saarbrücken, Germany

    Background/Purpose: Fibromyalgia (FM), often disputed and challenged, has emerged as a clear cluster of symptoms and co-morbidities, characterized by subjective complaints without physical or biomarker…
  • Abstract Number: 839 • 2013 ACR/ARHP Annual Meeting

    A Paradigm Change for Treatment Strategies for Fibromyalgia Syndrome Reflected By Recommendations of Recent Evidence-Based Interdisciplinary Guidelines Developed Independently in Three Countries

    Jacob N. Ablin1, Dan Buskila2, Howard Amital3, Mary-Ann Fitzcharles4, Yoram Shir5, Peter Henningsen6 and Winfried Häuser7, 1Rheumatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel, 2Ben-Gurion University, Beer-Sheva, Israel, 3Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Tel-hashomer, Israel, 4Rheumatology & Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 5Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 6Department Internal Medicine I, Klinikum Saarbrücken, Saarbrücken, Germany, 7Klinikum Saarbrücken, Saarbrücken, Germany

    Background/Purpose: Although the ideal treatment for fibromyalgia (FM) remains elusive, the medical community requires direction in the care of these patients.  The literature however abounds…
  • Abstract Number: 840 • 2013 ACR/ARHP Annual Meeting

    Fibromyalgia, Somatic Symptoms, and Mental Illness In View Of The 2013 Diagnostic and Statistical Manual Of Mental Disorders

    Frederick Wolfe1, Brian T. Walitt2, Robert S. Katz3 and Winfried Häuser4, 1National Data Bank for Rheumatic Diseases, Wichita, KS, 2Rheumatology, Washington Hospital Center, Washington, DC, 3Rush Medical College, Chicago, IL, 4Klinikum Saarbrücken, Saarbrücken, Germany

    Background/Purpose: Pain research conceptualizes fibromyalgia (FM) as a Physical or Somatic Symptom Disorder (PSD or SSD). However, the 2013 Diagnostic and Statistical Manual of Mental…
  • Abstract Number: 841 • 2013 ACR/ARHP Annual Meeting

    The Prevalence Of Fibromyalgia In The General Population – a Comparison Of The ACR 1990, 2010 and Modified 2010 Classification Criteria

    Gareth T. Jones1, Marcus Beasley1, Fabiola Atzeni2, Elisa Flüß1, Piercarlo Sarzi-Puttini2 and Gary Macfarlane1, 1Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, 2Rheumatology Unit, L. Sacco University Hospital, Milan, Italy

    Background/Purpose: In 1990 the ACR published criteria for the classification of fibromyalgia (FM), based on widespread pain and tenderness.  In 2010 new criteria were published…
  • Abstract Number: 842 • 2013 ACR/ARHP Annual Meeting

    A Cytokine/Chemokine Multiplex Assay That Is Sensitive and Specific For Fibromyalgia Compared To Controls, Systemic Lupus Erythematosus, and Rheumatoid Arthritis

    Daniel J. Wallace1, Igor Gavin2, Oleksiy Karpenko2 and Bruce S. Gillis3, 1Cedars-Sinai Medical Center, Los Angeles, CA, 2University of Illinois College of Medicine at Chicago, Chicago, IL, 3Department of Pathology, University of Illinois College of Medicine at Chicago, Chicago, IL

    Background/Purpose:   Fibromyalgia (FM) is a chronic pain and fatigue syndrome that affects about 6 million adults in the United States.  The clinical diagnosis of…
  • Abstract Number: 844 • 2013 ACR/ARHP Annual Meeting

    Level and Determinants Of Health Related Quality Of Life In Childhood-Onset Systemic Lupus Erythematosus

    Jordan T. Jones1, Shannen L. Nelson2, Janet Wootton3, Brianna Liberio4, Alexandria J. Greenler5, Jennifer L. Huggins1, Laura E. Schanberg6 and Hermine Brunner1, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Rheumatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 3Pediatric Rheumatology, Duke University Medical Center, Durham, NC, 4University of Cincinnati College of Medicine, Cincinnati, OH, 5Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 6Pediatrics, Duke University Medical Center, Durham, NC

    Background/Purpose: Childhood-onset lupus (cSLE) is a chronic autoimmune disease and its effect on health-related quality of life (HRQoL) has not been systematically established, nor does…
  • Abstract Number: 845 • 2013 ACR/ARHP Annual Meeting

    Improving Pneumococcal Vaccination Rate In The Pediatric Rheumatology Clinic

    Julia G. Harris1,2, Kristyn I. Maletta3, Bixiang Ren3 and Judyann C. Olson1,2, 1Medical College of Wisconsin, Milwaukee, WI, 2Children's Hospital of Wisconsin, Milwaukee, WI, 3National Outcomes Center, Children's Hospital of Wisconsin, Milwaukee, WI

    Background/Purpose:  This quality improvement project was conducted to increase pneumococcal vaccination rates in eligible Pediatric Rheumatology Clinic patients.  Streptococcus pneumoniae is a leading cause of…
  • Abstract Number: 846 • 2013 ACR/ARHP Annual Meeting

    Applying Choosing Wisely: Identifying Inefficiencies Of Antinuclear Antibody Subserology Testing In a Safety Net Health System

    Lisa A. Davis1, Barbara L. Goldstein2, Vivian Tran1, Angela Keniston3, Jinoos Yazdany4, Joel M. Hirsh1, Amy Storfa5 and Joann Zell2, 1Medicine, Division of Rheumatology, Denver Health and Hospital Authority, Denver, CO, 2Medicine, National Jewish Health, Denver, CO, 3Department of Medicine, Denver Health and Hospital Authority, Denver, CO, 4Medicine, University of California, San Francisco, San Francisco, CA, 5Medicine, Denver Health and Hospital Authority, Denver, CO

    Applying Choosing Wisely®:  Identifying Inefficiencies of ANA (antinuclear antibody) Subserology Testing in a Safety Net Health System Background/Purpose:   In 2013, the American College of…
  • Abstract Number: 847 • 2013 ACR/ARHP Annual Meeting

    Do Rheumatologists (and Other Specialists) Practice What We Preach?  A Study Of Serology Ordering Patterns With Attention To Subserologies When The Antinuclear Antibody By Enzyme Linked Immunosorbent Assay Is Negative; And The Clinical Significance Of These Positive Subserology Results

    David Bulbin1, Alicia Meadows1, Alfred E. Denio2, H. Lester Kirchner3, Sandi Kelsey4 and Harold Harrison4, 1Dept of General Internal Medicine, Geisinger Medical Center, Danville, PA, 2Dept of Rheumatology, Geisinger Health System, Danville, PA, 3Geisinger Center for Health Research, Geisinger Health System, Danville, PA, 4Dept of Pathology, Geisinger Medical Center, Danville, PA

    Background/Purpose: The American College of Rheumatology (ACR) was asked by the American Board of Internal Medicine to contribute to the “Choosing Wisely” campaign.  The first…
  • Abstract Number: 808 • 2013 ACR/ARHP Annual Meeting

    A Genome Wide Association Study Of Rheumatoid Arthritis Without Antibodies Against Citrullinated Peptides

    Lara Bossini-Castillo1, Carolien de Kovel2, Henrik Kallberg3, Marieke J.H. Coenen4, Paul P. Tak5, Marcel D. Posthumus6, Cisca Wijmenga7, Thomas W.J. Huizinga8, Annette H.M. van der Helm-van Mil9, Luis Rodriguez-Rodriguez10, Isidoro Gonzalez-Alvaro11, Miguel Angel Gonzalez-Gay12, Irene E. van der Horst-Bruinsma13, B.a.C Dijkmans14, G. J. Wolbink15, Roel A. Ophoff2, Piet L.C.M. van Riel16, Lars Klareskog3, J.B.a. Crusius17, Elisabeth Brouwer18, Javier Martin19, Niek de Vries5, René E.M. Toes9, Leonid Padyukov20 and Bobby P.C. Koeleman21, 1Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, Granada, Spain, 2Department of Medical Genetics, UMCU Utrecht, Utrecht, Netherlands, 3Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 4Human Genetics (855), Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 5Division of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Division of Clinical Immunology and Rheumatology and Department of Experimental Immunology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 6Department of Rheumatology, University of Groningen, University Medical Center, Groningen, Netherlands, 7Department of Genetics, University Medical Hospital Groningen, University of Groningen, Groningen, Netherlands, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 9Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 10Hospital Clínico San Carlos, Department of Rheumatology, Madrid, Spain, 11Servicio de Reumatología, Hospital Universitario de La Princesa, Madrid, Spain, 12Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV. Santander, Santander, Spain, 13Department of Rheumatology, VU University Medical Center, Amsterdam, Netherlands, 14Rheumatology, VU University Medical Center, Amsterdam, Netherlands, 15Rheumatology, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 16Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 17Pathology, VU University Medical Center, Amsterdam, Netherlands, 18Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 19Immunology, Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, Armilla (Granada), Spain, 20Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden, 21Department of Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is a common autoimmune disease that is associated with a progressive loss of the joints induced by a chronic inflammation of…
  • Abstract Number: 809 • 2013 ACR/ARHP Annual Meeting

    IgM Rheumatoid Factor As a Potentiator Of Anti-Citrullinated Protein Antibody Mediated Inflammation In Rheumatoid Arthritis

    Jeremy Sokolove1, Danye Cheng2, Dannette S. Johnson3, Ted R. Mikuls4 and William H. Robinson5, 1VA Palo Alto Healthcare System and Stanford University, Palo Alto, CA, 2VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 3Rheumatology, Jackson VA and University of Mississippi Medical Center, Jackson, MS, 4Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 5Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA

    Background/Purpose:   The co-occurrence of rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) is well described in rheumatoid arthritis (RA), and has been associated with…
  • « Previous Page
  • 1
  • …
  • 2192
  • 2193
  • 2194
  • 2195
  • 2196
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology